Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Oct;42(10):e2000091.
doi: 10.1002/bies.202000091. Epub 2020 Aug 12.

Might SARS-CoV-2 Have Arisen via Serial Passage through an Animal Host or Cell Culture?: A potential explanation for much of the novel coronavirus' distinctive genome

Affiliations

Might SARS-CoV-2 Have Arisen via Serial Passage through an Animal Host or Cell Culture?: A potential explanation for much of the novel coronavirus' distinctive genome

Karl Sirotkin et al. Bioessays. 2020 Oct.

Abstract

Despite claims from prominent scientists that SARS-CoV-2 indubitably emerged naturally, the etiology of this novel coronavirus remains a pressing and open question: Without knowing the true nature of a disease, it is impossible for clinicians to appropriately shape their care, for policy-makers to correctly gauge the nature and extent of the threat, and for the public to appropriately modify their behavior. Unless the intermediate host necessary for completing a natural zoonotic jump is identified, the dual-use gain-of-function research practice of viral serial passage should be considered a viable route by which the novel coronavirus arose. The practice of serial passage mimics a natural zoonotic jump, and offers explanations for SARS-CoV-2's distinctive spike-protein region and its unexpectedly high affinity for angiotensin converting enzyme (ACE2), as well as the notable polybasic furin cleavage site within it. Additional molecular clues raise further questions, all of which warrant full investigation into the novel coronavirus's origins and a re-examination of the risks and rewards of dual-use gain-of-function research.

Keywords: COVID-19; SARS-CoV-2; coronavirus; gain-of-function; intermediate host; pandemic; serial passage; virology.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Comment in

References

    1. Wadman M., Couzin‐Frankel J., Kaiser J., Matacic C., Science 2020. - PubMed
    1. Andersen K. G., Rambaut A., Lipkin W. I., Holmes E. C., Garry R. F., Nat. Med. 2020, 26, 450. - PMC - PubMed
    1. Tscherne D. M., Garcia‐Sastre A., J. Clin. Invest. 2011, 121, 6. - PMC - PubMed
    1. Salomon R., Franks J., Govorkova E. A., Ilyushina N. A., Yen H. L., Hulse‐Post D. J., Humberd J., Trichet M., Rehg J. E., Webby R. J., Webster R. G., Hoffmann E., J. Exp. Med. 2006, 203, 689. - PMC - PubMed
    1. Wu C., Yang Y., Liu Y., Zhang P., Wang Y., Li H., Wang Q., Xu Y., Li Mingxue, Zheng M., Chen L., Furin, a Potential Therapeutic Target for COVID‐19, 8 Apr. 2020, 22:46, fairdomhub.org/publications/539. - PMC - PubMed

MeSH terms

Substances